Steep Hill Expands Globally
Steep Hill, the global leader in cannabis science, genetics, research, testing, and analytics headquartered in Berkeley, California, announced plans this week to expand into the global cannabis market. In a press release from PRNewswire (1), Jmîchaeĺe Keller, the CEO and Chairman of the Board of Steep Hill, Inc., stated that the company will expand into Mexico and six new European Union markets offering full service cannabis quality assurance to those markets as they open and legalize cannabis.
According to the announcement, the licensee for Steep Hill Canada will expand their testing umbrella to include Steep Hill Mexico, Steep Hill Germany, Steep Hill Spain, Steep Hill France, Steep Hill Italy, Steep Hill Switzerland, and Steep Hill United Kingdom.
"I’m extremely pleased at the opportunity to partner with Steep Hill to bring safe cannabis and scientific integrity to emerging international markets,” Martin Shefsky, the CEO of Steep Hill Worldwide, said in the press release. “I anticipate that before long, full legalization will be implemented throughout the European Union and our presence will enable growers, producers, processors, and retailers to offer standardized tested cannabis for patients and consumers across the European Union, while also enabling us to create a platform to share scientific and technology developments throughout the global cannabis market. We are actively seeking operating partners with local market experience to join us in several of our strategic territories."
Keller also explained that in unregulated markets, Steep Hill wants to be on the ground supporting the legalization and regulatory process, and helping regulators avoid making the mistakes that other jurisdictions have made in the past. “We believe that our role as the industry standard, allows us to leverage our world-class scientific knowledge and state of the art technology to help regulators provide confidence in the marketplace that the cannabis patients consume is both safe and effective,” he said. “We look forward to collaborating closely with Martin and his group to strive for this gold standard, across all international borders."
For more information on Steep Hill, please visit www.steephill.com
References:
- https://www.prnewswire.com/news-releases/steep-hill-rapidly-expands-its-global-footprint-announces-license-agreements-for-mexico-germany-spain-france-italy-switzerland-and-the-united-kingdom-300639359.html
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.
Assessing Cannabis as a Harm Reduction Strategy: Insights from a Large-Scale Study
November 19th 2024A New Zealand study aimed to assess cannabis use as a harm reduction tool. Findings highlight lifestyle factors, and suggest cannabis-focused harm reduction strategies in reducing other substance use such as alcohol.
Ep 23, Part III: Accreditation in the Cannabis Industry with Susan Audino
October 24th 2024In Part III of this episode, host Evan Friedmann is joined by Susan Audino, PhD, founder of S.A. Audino & Associates, LLC, and co-founder of Saturn Scientific, LLC, to examine the complexities of sampling in the cannabis industry, emphasizing the need for proper sampling plans, and methods.
